The drug is delivered through using the company’s DepoFoam technology and extends the duration of the analgesia. In clinical trials, the drug provided pain relief for up to 72 hours compared with the analgesic’s normal time of less than seven hours.
Related Articles on Pain Management:
Study: Lower Dose of Corticosteroids Just as Effective as Higher for Shoulder Pain
Pain Makes Patients More Self-Absorbed
Nanoparticles May Improve Arthritis Pain Treatment
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
